Euroapi S.A. (EPA:EAPI)

Market Cap	274.83M
Revenue (ttm)	919.20M
Net Income (ttm)	-130.60M
Shares Out	95.23M
EPS (ttm)	-1.38
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	198,345
Average Volume	111,113
Open	2.910
Previous Close	2.886
Day's Range	2.896 - 3.124
52-Week Range	2.260 - 4.540
Beta	0.69
RSI	48.80
Earnings Date	Jul 29, 2025

About Euroapi

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances....

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2020
• Employees: 3,187
• Stock Exchange: Euronext Paris
• Ticker Symbol: EAPI

Financial Performance

In 2024, Euroapi's revenue was 919.20 million, a decrease of -9.79% compared to the previous year's 1.02 billion. Losses were -130.60 million, -31.15% less than in 2023.